rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1991-3-27
|
pubmed:abstractText |
The study objective was to evaluate the effects of long-term methadone use and human T-cell leukemia virus (HTLV) types I and II seropositivity on the distribution of lymphocyte subsets and on lymphocyte function as measured in vitro in intravenous drug users seronegative for human immunodeficiency virus type 1 (HIV-1).
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0002-9343
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
163-70
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1671730-Adult,
pubmed-meshheading:1671730-B-Lymphocytes,
pubmed-meshheading:1671730-Deltaretrovirus Antibodies,
pubmed-meshheading:1671730-HIV Antibodies,
pubmed-meshheading:1671730-HIV Seropositivity,
pubmed-meshheading:1671730-Humans,
pubmed-meshheading:1671730-Killer Cells, Natural,
pubmed-meshheading:1671730-Leukocyte Count,
pubmed-meshheading:1671730-Lymphocyte Subsets,
pubmed-meshheading:1671730-Male,
pubmed-meshheading:1671730-Methadone,
pubmed-meshheading:1671730-Street Drugs,
pubmed-meshheading:1671730-Substance Abuse, Intravenous,
pubmed-meshheading:1671730-T-Lymphocytes
|
pubmed:year |
1991
|
pubmed:articleTitle |
Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone.
|
pubmed:affiliation |
Center for the Biopsychosocial Study of AIDS, Miami, Florida.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|